Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research Units
Research output
Search by expertise, name or affiliation
Drug combinations in the treatment of refractory depression: A review
S. L. Stern, J. Mendels
Department of Psychiatry & Behavioral Sciences
Research output
:
Contribution to journal
›
Review article
›
peer-review
23
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Drug combinations in the treatment of refractory depression: A review'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Amaurosis
25%
Chemotherapeutic Agent
25%
Depression
50%
Drug
25%
Liothyronine
25%
Lithium
25%
Lithium Carbonate
25%
Methylphenidate
25%
Monoamine Oxidase Inhibitor
100%
Neuroleptics
25%
Reserpine
25%
Therapeutic Procedure
50%
Tryptophan
75%
Pharmacology, Toxicology and Pharmaceutical Science
Blindness
25%
Depression
50%
Drug
25%
Drug Combination
100%
Liothyronine
25%
Lithium
25%
Lithium Carbonate
25%
Methylphenidate
25%
Reserpine
25%
Tryptophan
75%
Neuroscience
Combination Drug
50%
Depression
50%
Lithium
25%
Lithium Carbonate
25%
Methylphenidate
25%
Monoamine Oxidase Inhibitor
50%
Reserpine
25%
Tricyclic Antidepressant
25%
Triiodothyronine
25%
Tryptophan
75%
Chemistry
Antipsychotic
25%
EC 1.4.3.4 (Monoamine Oxidase) Inhibitor
50%
L-Tryptophan
75%
Lithium
25%
Lithium Carbonate
25%
Methylphenidate
25%
Reserpine
25%
Safety
25%
Tricyclic Antidepressant Agent
25%
Biochemistry, Genetics and Molecular Biology
Monoamine Oxidase Inhibitor
50%
Triiodothyronine
25%
Tryptophan
75%